Rifaximin in treatment of patients with Irritable bowel syndrome

Turk J Gastroenterol. 2017 Jan;28(1):77-78. doi: 10.5152/tjg.2016.25122016.
No abstract available

Publication types

  • Comment

MeSH terms

  • Gastrointestinal Agents*
  • Humans
  • Irritable Bowel Syndrome*
  • Treatment Outcome

Substances

  • Gastrointestinal Agents